Related Experiment Video
Updated: May 8, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break
J M M van Oers1, Y Edwards1, R Chahwan1
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Abstract:
Loss of the DNA mismatch repair (MMR) protein MSH3 leads to the development of a variety of tumors in mice without significantly affecting survival rates, suggesting a modulating role for the MutSβ (MSH2-MSH3) complex in late-onset tumorigenesis. To better study the role of MSH3 in tumor progression, we crossed Msh3(-/-) mice onto a tumor predisposing p53-deficient background. Survival of Msh3/p53 mice was not reduced compared with p53 single mutant mice; however, the tumor spectrum changed significantly from lymphoma to sarcoma, indicating MSH3 as a potent modulator of p53-driven tumorigenesis. Interestingly, Msh3(-/-) mouse embryonic fibroblasts displayed increased chromatid breaks and persistence of γH2AX foci following ionizing radiation, indicating a defect in DNA double-strand break repair (DSBR). Msh3/p53 tumors showed increased loss of heterozygosity, elevated genome-wide copy-number variation and a moderate microsatellite instability phenotype compared with Msh2/p53 tumors, revealing that MSH2-MSH3 suppresses tumorigenesis by maintaining chromosomal stability. Our results show that the MSH2-MSH3 complex is important for the suppression of late-onset tumors due to its roles in DNA DSBR as well as in DNA MMR. Further, they demonstrate that MSH2-MSH3 suppresses chromosomal instability and modulates the tumor spectrum in p53-deficient tumorigenesis and possibly has a role in other chromosomally unstable tumors as well.
Insights
Loss of MSH3 protein impacts tumor development and progression. The MSH2-MSH3 complex suppresses chromosomal instability and modulates p53-driven cancer, highlighting its role in DNA repair and mismatch repair.
Area of Science:
- Genetics
- Cancer Biology
- Molecular Biology
Background:
- Loss of DNA mismatch repair (MMR) protein MSH3 is linked to various tumors.
- The MutSβ (MSH2-MSH3) complex may modulate late-onset tumorigenesis.
- MSH3's specific role in tumor progression requires further investigation.
Purpose of the Study:
- To investigate the role of MSH3 in p53-driven tumorigenesis.
- To determine MSH3's impact on DNA double-strand break repair (DSBR) and chromosomal stability.
- To elucidate the function of the MSH2-MSH3 complex in suppressing tumor development.
Main Methods:
- Crossed Msh3(-/-) mice with p53-deficient mice.
- Analyzed survival rates and tumor spectrum.
- Assessed DNA double-strand break repair (DSBR) in mouse embryonic fibroblasts.
- Examined genomic alterations (LOH, CNV, MSI) in tumors.
Main Results:
- Msh3/p53 mice showed a shift from lymphoma to sarcoma, indicating MSH3 modulates p53-driven tumorigenesis.
- Msh3(-/-) fibroblasts exhibited defects in DSBR, evidenced by increased chromatid breaks and persistent γH2AX foci.
- Msh3/p53 tumors displayed increased LOH and CNV, with a moderate MSI phenotype compared to Msh2/p53 tumors.
- MSH2-MSH3 suppresses tumorigenesis by maintaining chromosomal stability.
Conclusions:
- The MSH2-MSH3 complex is crucial for suppressing late-onset tumors via DNA DSBR and MMR.
- MSH2-MSH3 inhibits chromosomal instability and influences the tumor spectrum in p53-deficient contexts.
- MSH2-MSH3 may play a role in other chromosomally unstable tumors.
Related Concept Videos
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
